Variant report
Variant | esv20608 |
---|---|
Chromosome Location | chr2:234543356-234544945 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:122)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:234544462-234544512 | U87 | brain: | n/a |
2 | chr2:234544271-234544321 | H1-hESC | embryonic stem cell: | embryo |
3 | chr2:234544462-234544512 | HRE | kidney: | n/a |
4 | chr2:234544462-234544512 | SAEC | small airway: | n/a |
5 | chr2:234544462-234544512 | HL-60 | blood: | n/a |
6 | chr2:234544271-234544321 | HCT-116 | colon: | n/a |
7 | chr2:234544462-234544512 | HIPEpiC | eye: | n/a |
8 | chr2:234544271-234544321 | MCF-7 | breast: | n/a |
9 | chr2:234544462-234544512 | AG04450 | lung: | fetal |
10 | chr2:234544271-234544321 | SK-N-SH_RA | brain: | n/a |
11 | chr2:234544271-234544321 | PFSK-1 | brain: | n/a |
12 | chr2:234544271-234544321 | HL-60 | blood: | n/a |
13 | chr2:234544462-234544512 | PrEC | prostate: | n/a |
14 | chr2:234544462-234544512 | NH-A | brain: | n/a |
15 | chr2:234544462-234544512 | GM12878 | blood: | n/a |
16 | chr2:234544462-234544512 | A549 | lung: | n/a |
17 | chr2:234544271-234544321 | HepG2 | liver: | n/a |
18 | chr2:234544462-234544512 | H1-hESC | embryonic stem cell: | embryo |
19 | chr2:234544271-234544321 | LNCaP | prostate: | n/a |
20 | chr2:234544271-234544321 | HAEpiC | amniotic membrane: | n/a |
21 | chr2:234544462-234544512 | Hela-S3 | cervix: | n/a |
22 | chr2:234544462-234544512 | SK-N-SH | brain: | n/a |
23 | chr2:234544271-234544321 | AG09319 | gingival: | n/a |
24 | chr2:234544462-234544512 | HRPEpiC | eye: | n/a |
25 | chr2:234544462-234544512 | T-47D | breast: | n/a |
26 | chr2:234544271-234544321 | K562 | blood: | n/a |
27 | chr2:234544271-234544321 | GM19239 | blood: | n/a |
28 | chr2:234544271-234544321 | ProgFib | skin: | n/a |
29 | chr2:234544271-234544321 | ECC-1 | luminal epithelium: | n/a |
30 | chr2:234544271-234544321 | HEEpiC | esophagus: | n/a |
31 | chr2:234544271-234544321 | HRCEpiC | kidney: | n/a |
32 | chr2:234544271-234544321 | RPTEC | kidney: | n/a |
33 | chr2:234544271-234544321 | NH-A | brain: | n/a |
34 | chr2:234544462-234544512 | ovcar-3 | ovarian: | n/a |
35 | chr2:234544462-234544512 | HRCEpiC | kidney: | n/a |
36 | chr2:234544462-234544512 | CMK | blood: | n/a |
37 | chr2:234544462-234544512 | GM12892 | blood: | n/a |
38 | chr2:234544462-234544512 | HAEpiC | amniotic membrane: | n/a |
39 | chr2:234544462-234544512 | MCF10A-Er-Src | breast: | n/a |
40 | chr2:234544271-234544321 | AG09309 | skin: | n/a |
41 | chr2:234544271-234544321 | HPAEpiC | pulmonary alveolar: | n/a |
42 | chr2:234544462-234544512 | K562 | blood: | n/a |
43 | chr2:234544271-234544321 | GM12892 | blood: | n/a |
44 | chr2:234544271-234544321 | ovcar-3 | ovarian: | n/a |
45 | chr2:234544462-234544512 | AG09309 | skin: | n/a |
46 | chr2:234544462-234544512 | GM12891 | blood: | n/a |
47 | chr2:234544462-234544512 | NT2-D1 | testis: | n/a |
48 | chr2:234544271-234544321 | PrEC | prostate: | n/a |
49 | chr2:234544462-234544512 | AoSMC | blood vessel: | n/a |
50 | chr2:234544462-234544512 | SK-N-SH_RA | brain: | n/a |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
UGT1A10 | CpG island |
ENSG00000228949 | chromatin interactions |
ENSG00000228445 | chromatin interactions |
ENSG00000227802 | chromatin interactions |
ENSG00000224287 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs78988334 | chr2:234543362-234543363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs541695478 | chr2:234543406-234543407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs75921503 | chr2:234543415-234543416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560977950 | chr2:234543416-234543417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574346786 | chr2:234543425-234543426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs540548975 | chr2:234543467-234543468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs561363833 | chr2:234543545-234543546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs560169392 | chr2:234543555-234543556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs532411705 | chr2:234543567-234543568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs141950305 | chr2:234543586-234543587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562624277 | chr2:234543628-234543629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs201283363 | chr2:234543629-234543630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs34516042 | chr2:234543757-234543758 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
14 | rs531883885 | chr2:234543842-234543843 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
15 | rs548390541 | chr2:234543843-234543844 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
16 | rs568470173 | chr2:234543885-234543886 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
17 | rs2741032 | chr2:234543899-234543900 | Weak transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs547738684 | chr2:234543910-234543911 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
19 | rs570834051 | chr2:234543947-234543948 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
20 | rs539699748 | chr2:234544055-234544056 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
21 | rs556350478 | chr2:234544097-234544098 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
22 | rs28969976 | chr2:234544109-234544110 | Weak transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs537989173 | chr2:234544117-234544118 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
24 | rs554343189 | chr2:234544161-234544162 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
25 | rs113908691 | chr2:234544165-234544166 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
26 | rs74647673 | chr2:234544166-234544167 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
27 | rs539863241 | chr2:234544187-234544188 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
28 | rs183044833 | chr2:234544254-234544255 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
29 | rs570772348 | chr2:234544283-234544284 | Weak transcription | CpG islandChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
30 | rs577211755 | chr2:234544329-234544330 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
31 | rs188481063 | chr2:234544345-234544346 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
32 | rs546111444 | chr2:234544348-234544349 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
33 | rs562720355 | chr2:234544380-234544381 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
34 | rs531513033 | chr2:234544385-234544386 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
35 | rs149873740 | chr2:234544388-234544389 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
36 | rs562060125 | chr2:234544400-234544401 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
37 | rs527761051 | chr2:234544402-234544403 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
38 | rs28969678 | chr2:234544406-234544407 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs570474196 | chr2:234544410-234544411 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
40 | rs145951009 | chr2:234544441-234544442 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
41 | rs532635000 | chr2:234544454-234544455 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
42 | rs550055899 | chr2:234544457-234544458 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
43 | rs192998241 | chr2:234544462-234544463 | Weak transcription Enhancers | CpG islandChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
44 | rs45557331 | chr2:234544466-234544467 | Weak transcription Enhancers | CpG islandChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
45 | rs555894785 | chr2:234544528-234544529 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
46 | rs45464594 | chr2:234544568-234544569 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs35794478 | chr2:234544573-234544574 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
48 | rs17864678 | chr2:234544610-234544611 | Enhancers Flanking Active TSS | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
49 | rs553811392 | chr2:234544642-234544643 | Enhancers Flanking Active TSS | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
50 | rs576905738 | chr2:234544670-234544671 | Enhancers Flanking Active TSS | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Cancer | 22429812 | CNVD |
Bladder cancer | 21909424 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Mental retardation | 20152051 | CNVD |
Cancer | 21183584 | CNVD |
Albright''s disease | 22277900 | CNVD |
Brachydactyly-Mental Retardation Syndrome | 22470819 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Autism | 18414403 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20605837 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:234538000-234544600 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
2 | chr2:234544400-234545200 | Enhancers | Rectal Mucosa Donor 31 | rectum |
3 | chr2:234544600-234544800 | Enhancers | Duodenum Mucosa | Duodenum |
4 | chr2:234544600-234544800 | Flanking Active TSS | Rectal Mucosa Donor 29 | rectum |
5 | chr2:234544600-234545000 | Enhancers | Colonic Mucosa | Colon |
6 | chr2:234544800-234547600 | Active TSS | Duodenum Mucosa | Duodenum |
7 | chr2:234544800-234548400 | Active TSS | Rectal Mucosa Donor 29 | rectum |